cnbc.com / .cnbc-com-health-care / Page 2

Karen Knudsen is leading Sean Parker's cancer immunotherapy incubator where philanthropy and venture capital meet.

It is the panel's first meeting with Kennedy's newly appointed members, many of whom are well-known vaccine critics.

The health insights tracked by Oura Ring will be utilized by Maven Clinic's doctors and care teams as part of a new partnership.

The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating billions of dollars annually.

Sword Health is pulling in additional capital as it expands into mental health care with a new artificial intelligence tool.

Companies like AstraZeneca, Daiichi Sankyo, Pfizer and Merck are learning from previous setbacks in the ADC space to improve their efficacy and safety.

Novo Nordisk's drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC's Disruptor 50 List.

Oura has leaned further into providing wearers of its eponymous connected ring with a fuller picture of overall health and wellness.

Some experts say the move undermines science, disrupts a trusted regulatory process and could sow public distrust in vaccinations and federal health agencies.

Merck's shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.